Sun BioPharma (SNBP) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

SNBP vs. HILS, ENSC, SNGX, ARTL, ZVSA, EVOK, MBIO, LIPO, CING, and VRPX

Should you be buying Sun BioPharma stock or one of its competitors? The main competitors of Sun BioPharma include Hillstream BioPharma (HILS), Ensysce Biosciences (ENSC), Soligenix (SNGX), Artelo Biosciences (ARTL), ZyVersa Therapeutics (ZVSA), Evoke Pharma (EVOK), Mustang Bio (MBIO), Lipella Pharmaceuticals (LIPO), Cingulate (CING), and Virpax Pharmaceuticals (VRPX). These companies are all part of the "medical" sector.

Sun BioPharma vs.

Hillstream BioPharma (NASDAQ:HILS) and Sun BioPharma (NASDAQ:SNBP) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability, community ranking and analyst recommendations.

Hillstream BioPharma's return on equity of 0.00% beat Sun BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Hillstream BioPharmaN/A -188.44% -149.61%
Sun BioPharma N/A N/A N/A

In the previous week, Sun BioPharma's average media sentiment score of 0.00 equaled Hillstream BioPharma'saverage media sentiment score.

Company Overall Sentiment
Hillstream BioPharma Neutral
Sun BioPharma Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hillstream BioPharma
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sun BioPharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Sun BioPharma received 5 more outperform votes than Hillstream BioPharma when rated by MarketBeat users. Likewise, 54.55% of users gave Sun BioPharma an outperform vote while only 50.00% of users gave Hillstream BioPharma an outperform vote.

CompanyUnderperformOutperform
Hillstream BioPharmaOutperform Votes
1
50.00%
Underperform Votes
1
50.00%
Sun BioPharmaOutperform Votes
6
54.55%
Underperform Votes
5
45.45%

13.4% of Hillstream BioPharma shares are held by institutional investors. 30.2% of Hillstream BioPharma shares are held by insiders. Comparatively, 30.0% of Sun BioPharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hillstream BioPharmaN/AN/A-$8.47M-$0.72-0.50
Sun BioPharmaN/AN/AN/AN/AN/A

Summary

Sun BioPharma beats Hillstream BioPharma on 4 of the 6 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNBP vs. The Competition

MetricSun BioPharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$4.25M$6.78B$4.98B$7.44B
Dividend YieldN/A3.05%2.98%3.94%
P/E RatioN/A11.38212.9018.39
Price / SalesN/A314.982,352.5490.24
Price / CashN/A30.0847.2135.26
Price / BookN/A5.524.604.27
Net IncomeN/A$141.67M$102.97M$213.82M

Sun BioPharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HILS
Hillstream BioPharma
0 of 5 stars
$0.38
+2.7%
N/A-54.8%$4.06MN/A-0.531Gap Up
ENSC
Ensysce Biosciences
2.2504 of 5 stars
$0.57
+5.6%
$7.00
+1,134.6%
-84.2%$4.16M$2.23M-0.117Short Interest ↓
News Coverage
SNGX
Soligenix
0.1826 of 5 stars
$0.40
-2.4%
$3.00
+650.0%
-75.1%$4.21M$840,000.00-0.4413Short Interest ↑
ARTL
Artelo Biosciences
2.3204 of 5 stars
$1.31
+0.8%
$5.00
+281.7%
-50.1%$4.23MN/A-0.425Short Interest ↓
ZVSA
ZyVersa Therapeutics
1.3119 of 5 stars
$0.57
flat
$12.00
+1,997.9%
-99.0%$4.34MN/A0.007Stock Split
Short Interest ↓
EVOK
Evoke Pharma
0 of 5 stars
$0.44
-2.2%
N/A-76.7%$3.76M$5.18M-0.194Short Interest ↓
Gap Down
MBIO
Mustang Bio
2.0982 of 5 stars
$0.36
+5.9%
$17.25
+4,695.7%
-91.7%$3.74MN/A-0.0680Short Interest ↓
Gap Up
LIPO
Lipella Pharmaceuticals
2.6722 of 5 stars
$0.70
-2.8%
$2.00
+184.1%
-62.7%$4.40M$449,617.000.005
CING
Cingulate
2.5448 of 5 stars
$0.88
-1.1%
$8.00
+810.4%
-96.0%$4.40MN/A-0.0315Short Interest ↓
Gap Up
VRPX
Virpax Pharmaceuticals
0 of 5 stars
$3.16
-4.2%
N/A-57.7%$3.70MN/A-0.277Short Interest ↓
News Coverage
Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:SNBP) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners